Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: E.J. Neitz Jr who wrote (7034)	8/28/1998 7:26:00 AM
From: Robert K.	Respond to of 17367

Opalapril-I wouldnt answer ANY probing questions from someone I dont know. You dont even know if they ARE from xoma. Step 1 ask Ellen. If NOT from xoma I would venture lawyers or a bid coming If is xoma then just ask why. I am back to the basics here. My focus is almost only on if drug works or not. Thats all that really matters in longterm IMO. If you bought at 5 or 8 and drug works you should be well rewarded. If you buy at 2 so much the better. If it fails then thats another story. Remember, meningo is NOT the whole bpi story.

To: E.J. Neitz Jr who wrote (7034)	8/28/1998 9:51:00 AM
From: celeryroot.com	Read Replies (1) \| Respond to of 17367

McKenzie Group is a reputable company. Perhaps Xoma is puzzled at their stock price and is investigating possible short problem.